Opinion Pieces Discuss Various Topics Related To COVID-19, Including Testing, Vaccines, Africa’s Response To Pandemic

Devex: Opinion: Making UNGA matter in the age of pandemic
Hardin Lang, vice president for programs and policy at Refugees International (9/22).

Foreign Affairs: One Virus, Two Americas
Ashish Jha, dean of the Brown School of Public Health (9/22).

New York Times: These Coronavirus Trials Don’t Answer the One Question We Need to Know
Peter Doshi, associate professor at the University of Maryland School of Pharmacy, and Eric Topol, professor of molecular medicine at Scripps Research (9/22).

STAT: Fast, low-cost testing is essential for averting a second wave of Covid-19
Menachem Fromer, data scientist, R&D lead for COVID-19 population health and mental health at Verily Life Sciences, and associate professor of genetics and genomic sciences and psychiatry at Icahn School of Medicine at Mount Sinai in New York, and colleagues (9/23).

Washington Post: Africa has defied the covid-19 nightmare scenarios. We shouldn’t be surprised
Karen Attiah, Global Opinions editor at the Washington Post (9/22).

Washington Post: Beware of covid-19 vaccine trials designed to succeed from the start
William Haseltine, chair and president of ACCESS Health International (9/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.